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Organ and tissue transplants have decreased the morbidity 
associated with such medical problems as uremia and heart 
rrhe success of organ transplants has paralleled advances in trans-
i 
plantation immunology. Medical problems associated with bone marrow 
destruction or replacement with its resultant could be' 
temporarily alleviated by the use of leukocyte transfusions. Though 
transfuqions have been done, the efficacy has not evalu-
ated by direct measurement of physiological function of the transfused 
cells. 
To determine the potential efficacy of leukocyte transfusion 
in 12 normal subjects, neutrophil kinetic studies and immunological 
tests to detect leukocyte antibodies were employed. The phys 
cal behavior of the neutrophils was followed by labeling them w':ith 
radioactive diisoprophylfluorophosphate (DF32p ) in vitro, and then 
transfusing them. Interval sampling of these labeled cells allowed 
their half-
done with 
time (T~) to be computed. This was first 
2 
neutrophils to obtain the normal T~ of the sub-
2 
ject r sown Labeled isologous neutrophils were then tranp-
fused into that subject and the of the donor cells in the rec is 
circulation was measured. transfusion sera were collected from 
each rec after 6 and 13 days, and tested for leukoagglutinins. 
Erythrocyte and lymphocyte cytotoxic antibodies were tested for as well, 
but none were found in these sera. 
Four of the 12 recipients had accelerated isologous neutrophil 
disappearance rates, while 3 of the 12 demonstrated leukoagglutin1n 
formation. Tw'o of the L~ subjects with shortened neutrophil survival 
times formed leukoagglutinins, and 2/3 of those with leukoaggluti.nins 
had shortened survival times. A 2x2 Chi-square evaluation of these 
data indicated no significant association between the neutrophil 
survival time and leukocyte antibody formation (p = 0.15). 
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INTRODUCTION 
The value of whole blood transfusion has been known for many 
years. It is a life- procedure after hemorrhage and in disease 
states causing anemia. Blood transfusion, however, only became a 
relatively safe after the discovery of the main red cell 
isoantigens by Landsteiner in 1901 (Weiner, 1962). Even after the 
discovery of the main blood groups and cross matching procedures, 
blood transfusion has undergone continuous Ghange. Today, the ex-
pectation of 
(Zmdjewski, 1968). 
new red cell antigens is just as as ever 
Today the emphasis in research is focused on organ and tissue 
transplantation; leukocyte transfusion is a tissue transplant. 
Leukocyte transfusion, for therapy, could benefit neutropenic 
(Graw, 1971). Neutropenia, or in general) is 
most commonly associated with acute luekemias or other marrow replace-
ment disease, marrow depression, and cytotoxic marrow damage. Even 
the stimulus of an infection, these fail to produce 
poor blood, although 
cut down tremendously the for-
leukocytes. The use of 
of no help to a neutrophenic) will 
mation of leukocyte isoantibodies. if these patients are 
go to be typed for histocompatibility, they spould have blood drawn 
before transfusion (histocompatibil is a matching of donor and 
recipient tissue antigens). Zmijewski (1967) found that as little 
2 
as 1- of isologous leukocytes in a blood sample taken from a 
recently transfused patient could invalidate typing tests. 
To be of therapeutic value, the transfused neutrophils must 
function normally (Eaab, 1961). Past leukokinetic studies have indicated 
that many times isologous neutrophils (those obtained from another person) 
do not function in a normal fashion. These studies have shown that 
in as many as one-third of nonnal subjects isologous neutrophils will 
have an abnormally short disappearance time. Even though a subject 
has a normal neutrophil survival value following isologous transfusion, 
are the isologous leukocytes going to function in a physiologically 
helpful manner? Kauder, et ale (1965',), found that even though the 
transfused granUlocytes marginate normally and leave the circulation, 
they fail to enter inflanrrnatory exudates as readily as homologous 
granulocytes. 
The purpose of this study is to investigate whether a shortened 
neutrophil disappearance time is associated with an antibody against 
the leukocytes, or is independent of an antigen-antibody reaction. 
REVIEW OF LITERATURE 
The criterion of success of early le transfusions was 
clinical improvement in the transfused subject, without 
white cell antigens or leukokinetics. Yankee, et al. ( 
improved clinical condition j.n infected 
fused with granulocytes from normal donors. 
reported in acute leukemics after transfusion with 
from patients with chronic myelogenous leukemia (Freire 







schedules so that "cures" could be obtained. In a controlled study 
with dogs, marrow failure was produced with radiation, and a 
established by injecting Escherichia coli. After the became very 
were transfused with leukocytes collected from normal 
The were collect.eo. usj.ng a NCr-IBM Blood Cell 
of the septicemia determined the success of the trans-
fusion ( 
Methods have been devised in the last decade which make 
possible to follow the behavior of neutrophils after transfusion, thus 
allowing a bet.ter assessment of transfusion success. Neutrophil kinetics 
can be studied by the cells with radioactive dii.soprophyl-
fluorophosphate (DP32p ), in vitro. DF32p is a potent irreversible este-
rase inhibitor which becomes firmly attached to the neutrophils. The 
other cells and formed elements of the blood are labeled little or not 
4 
at all (Athens, 1959). After transfusion, the labeled netrophils 
leave the c ircuJ,a tion in a random (exponential) fashion, w'i th a mean 
half disappearance time (TI ) of 6.7 hours in normal subjects 
2 
(Cartwright, 1964). 
Mauer, et ale (1960) chose ten normal pairs of sub for an 
isologous transfusion leukokinetic study. None had received blood 
transfusions previously. Autologous transfusion, with DF32p labeled 
granulocytes, showed that each subject had a normal blood neutrophil 
TI . After isologous transfusion of labeled neutrophils, however, 
2 
two of the ten had a of 2.5 and 1.2 hours. A patient who had 
been transfused many times previousQhad a TI of 0.8 hours. Similar 
2 
results were obtained later by this same group, when tW'leve subjects 
received isologous transfusions. After transfusion the Tl of the 
2 
iSOlogous granulocytes was abnormally short in five of the twelve, 
compared with their autologous studies. It was suggested that anti-
genic differences, between donor and recipient, were responsiblR for 
the rapid disappearance of the granulocytes from the circulation in 
these five subjects (Kauder, ). 
It has been confirmed that the erythrocyte antigens systems 
(ABO, Rh, MNSs, Kell, Jk, Duffy), platelet antigens (Ko) and serum 
alloantigens (Gm, Gc, Lp, Ag) have no significant effect on histo~ 
compatibility. As a consequence, most attention has been given to 
the white cell antigens (Dausset, 1970). The first leukocyte group 
(Mac) was described by Dausset in 1958. The other antigens of the 
HL-A (Human Leukocyte-locus A) system have been discovered through 
continued study. HL-A antigens are found on the leukocytes, platelets, 
and the solid tissues of the body_ They are not found on erythro-
cytes or in serum. 
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Agglutinating antibodies against the neutrophilic white eells 
Were first brought to light in a transient state known as neonai;.al 
neutrqpenia. Because tile neutropenia disappeared in 2-4 weeks, it 
was thought that ma-t.ernal antibodies could be responsible; as in 
erythroblastosis fetalis. By incubating the newborn's leukocytes wi th 
its mother's serum, it ~as found that agglutination of the leukocytes 
took place (Lalezari, 1965; Van Rood, 1961; Payne, 1961+). Since then 
leukoagglutinins have been demonstrated in the sera of multiparous 
females where fetal leukocytes appeared to be the only antigenic 
stimulus. The fact that passive transfer of leukoagglutinins across 
the placental barrier occurs in man, places pathogenic significance 
on these antibodies. The antibodies in the mother are directed 
against some of the antigens of the father. They are also directed 
against some of the antigens inherited from the father and present 
in other siblings. They can be detected in an infant's serum during 
the period of neutropenia. Bone marrow' examination of the neutropenic 
infant reveals a predominance of immature myeloid elements with a 
complete absence of mature neutrophils (Lalezari, 1966b). To date 
three distinct neutrophil specific antigens have been found. They 
have been designated NAl, NBl, and VAZ (Lalezari, 197oa.), and are so 
called "high incidence" antigens. Antisers to these antigens will 
agglutinate leukocytes of the general population with an incidence 
of 56%, 97% and 89.7% respectively. These antigens are not found on 
erythrocytes, solid tissues, or any leukocyte except the neutrophil. 
6 
The development of 
multritransfused 
iso-antibodies also takes place in 
1956; Payne, 1958). Ceppellini ( 
monospecific antisers, repeatedly trans:-in an effort to produce 
fused white cells from a s donor to the same recipient. He divided 
recipients into two groups according to different transfusion schedules. 
The first group received 14 to 16 whole blood transfusions of 80 ml a 
week. were lnserted every four weeks sufftctent to 
spread the transfusions over a full year~ Twenty-seven percent of these 
recipients leukoagglutinins. The second group re-
ceived transfus ions of 250 ml of whole blood every 45 to 
Twelve of these recipients developed strong 
within one year. The first schedule was considered a more efficient 
method of developing agglutinins, requirmg ml of blood to develop 
the first detectable leukoagglutinin. The second schedule required 
750 ml of blood before an agglutinin was detectable. 
The evidence that white cells are a source of transplantation 
, is supported by their ability to sensitize a recipient 
a skin graft (Friedman, 1961). transfusion is in 
fact a tissue graft, and as such could be expected to reject rapidly 
in a sensitized individual. The correlation of graft rejection and 
antibody formation should be simple, based on one antigen to one 
antibody relationship, but it is not. There are several technical 
difficulties which together make the correlation a hard task, including: 
non-availability of strong antisers directed against one antigen, no 
cell panels convenient at the time needed and test results that can 
not be duplicated (Ceppellini, . Zmijew'ski, 1965). 
7 
Leukocyt.e ant.ibodies can be det.ect.ed by several different. 
t.echniques, however, t.he leukoagglut.inat.ion and lymphocyt.ot.ixic met.hods 
have been used more ext.ensively and have been more int.ensively st.udied 
(Zmijewski, 1966). 
In response to t.his problem, an at.t.empt. was made t.o correlat.e 
t.he agglut.inat.ing and cyt.ot.oxic ant.ibodies (Bodmer, et. ale 1966). 
Leukocyt.e ant.isers were t.est.ed against. a whit.e cell panel 
leukogglut.inat.ion and lymphocyt.e cyt.ot.oxic t.echniques. 
bot.h 
found 
good agreement. bet.ween t.he two assays, but with consistently more 
positive results using the agglutination test (X2 = 85.3 with 1 df). 
When differences existed, the antisers usually had very strong 
agglutinating properties. Cells sufficient in quantity to remove 
the agglutinating activity also removed all cytotoxic activity. 
The differences between the two tests could be attributed to the sera, 
which were selected on the basis of their agglutinating activity. 
Ceppellini (1965b), however, said that no correlation should be drawn 
between the EDTA-type leukoagglutinins and any of the antibodies 
detected by cytotoxicity. Zmijewski (1966) is in general agreement 
with this opinion, as he concluded that many sera could have both 
agglutinating and cytotoxic activity which is directed against dif-
ferent Use of the cytotoxic methods as a test of choice 
has become more prevalent since organ transplantation problems have 
been realized. Walford (1964) suggested that cytotoxicity is a 
better method to detect lymphocyte antigens than leukoagglutination. 
Some papers have stressed that both agglutination and cytotoxic methods 
8 
must be used when testing for histocompatibility, at least until a 
more definite association can be drawn between the antigens detected 
by the two tests (Zmijewski, 1966). 
Lymphocyte cytotoxicity is complicated by some of the same prob-
lems as leukoagglutination. In a study to better determine the re-
la tionship between the HL-A antigens, Dausset) et ale (1970)., confirmed 
their earlier findings (Dausset, 1968) that the HL-A region of the 
human chromosome includes at least two subloc:i, with at least six 
antigens determined at the first sublocus and at least eight antigens 
at the second. Population studies have been complicated by sera 
which react with cells of other specificities. Such cross reactions 
have been observed between HL-A2 and Da15, HL-A5 and Da6, HL-A9 and 
Da7. A cytotoxicity-negative, ab$orption .. positive phenomenon was 
observed when HL-A5 and HL .. A7 antisers did not kill, but were absorbed 
by Da6 and Da9 cells respectively. Cytotoxicity-negative, absorption-
positive reactions were first noted by Ceppellini (1965a), and are 
analogous to agglutination-negative, absorption-positive reactions 
in leukoagglutination tests. Cross absorption procedures are used 
when checking for monospecific antisera (Zmijewski, 1968). During 
a cross absorption study to select monospecific leukoagglutinins j it 
was abserved that some cell samples selectively absorbed antibody, 
but Were not agglutinated by it. This phenomenon has been termed 
agglutination-negative, absorption-positive, and is a potential source 
of error (Van Rood, 1961). 
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Aggluti.nation Tests 
Zmijewski (1968) indicated that even the best leukocyte 
nation tests are fickle techniques, complicated by results that f3eem 
to go against the facts of serology. The antibodies detected the 
1eukoagglutination tests react with antigens common to s, 
platelets, and some solid tissues. 
A test should be sensitive enough to detect low concent.rations 
of antibody, and yet not a false positive result. Sensitivity 
seems to be correlated with how the white cell suspension is prepared 
and how the cells are incubated with the antisers. The blood 
samples for most leukoagglutination methods are anticoagluated with 
5% Na2EDTA, although 10% Na2
EDTA and difibrination have also been 
used (Zmijewski, Leukocytes prepared from blood anticoagu-
lated with EDTA are preferred for testing since these leukocytes 
show better reproducibility (80%) than the test leukocytes from 
def ibrina ted blood ( 60%). Reproducibil is determined test-
sera t the same donors I leukocytes on different days (Van 
Rood, 1963). Complete removal of platelets is said to reduce the num-
ber of false positives (Lalezari, 1964 j Zm ijewski, 1968). Van Rood 
), however, said that do not cause any complications. 
He based his reasoning on the fact that platelets have many of the 
same antigens as white cells, not into account the fact that 
the stickiness of platelets w ill cause a white cell suspension to 
appear as though it w'ere agglutinated. 
Incubation times vary tremendously w'ith the agglutination 
method anywhere from minutes (Payne, ) to 18 hours 
(Lalezari, 1964). Incubation time is limited by the ability of the 
leukocytes to retain their immunological and 
istics, and this seems to be determined by the 
~u~~~nical character-
used to sediment the 
red cells. Lalezari (196+-, 1962, 
'red cell sedimentor penni ts 
whe reas those using 
found the use of Polybrene as a 
incubation of the white cl'~lls, 
gelatine, and polyvinyl-
pyrrolidone (PVP), do not give good results when incubated any. more 
than three hours. With long incubation times to detect trace concen-
trations of antibody, and the addition of excess EDTA to reaction 
mixtures to inhibit false positives, one must consi.der t.he possibility 
of false negatives occurring. More some of the leukoggluti-
nation methods have been modified to allow micro techniques to be 
used (Payne, 1967'; Lalezari, 1970b). 
The physiologic activity of the cell donor can also affect 
agglutination results. Leukocyte reactivity is increased after 
strenuous exercise, and excess alcohol consumption. It 
is follow'ing mild exercise, cold, or heat. For consistent 
results in testing, blood should be drawn from a resting, fasting 
(Zmijewski, 1967). 
Cytotoxic Tests 
Lymphocytotoxie methods can be used in conjunction with the 
tests to obtain a better estimate of the number or 
type of antibodies present in a serum. The tests have 
shown about the same amount of diversity prevalent in leukoagglu-
tination tests. Cytotoxic serum is obtained from multiparous women, 
11 
multitransfused patients; and immunized subjects (Walford, 1964). 
Specific immunization is obtained by sensitization of a subject with 
leukocyte injections or skin allografts (Dausset, 1970). Cytotoxic 
antibodies detect antigens common to leukocytes, platelets (Lalezari, 
1970) and the solid tissues. Anticoagulation of blood for cell 
samples has been accomplished by either defibrination (Walford, 1964), 
or heparinization (rrerasaki, 1964; Engelfreit, 1966). Early tests 
obtained white cells free of erythrocytes by differential centri-
fugation, osmotic shock (Walford, 1964) or gelatine precipitation 
(Walford, 1964). La.ter tests have used dextran (Zmijewski, 1966; 
Engelfreit, 1966), PVP, PVP with specific red cell antiserum, or 
specific red cell antiserum alone (Mittal, 1968). Engelfreit (1966) 
used a suspension of mixed leukoGytes for his cytotoxicity test, 
whereas all other tests used a suspension of lymphocytes only. Gran-
ulocytic cells can be removed by absorption on a cover glass (Terasaki, 
1964), nylon fleece (Walford, 1964), or On small glass beads (Mlttal, 
1968) . After incubation of the cells (30 minutes- -all tests) w'i th 
antisers at room temperature, all of the different test methods agree 
that exposure of the cells to complement is necessary. Cytotoxicity 
is determined by exclusion of trypan blue or eosin dye by living 
cells. 
MATERIALS AND METHODS 
I. Experimental Protocol 
Sub,jects were chosen from inmates of the Utah State Prison. 
were healthy men who had not received prior blood transfusion 
and had no history of venereal disease or hepatitis. Subjects were se-
lected as pairs on the basis of red cell,antigens and cross match com-
patibility (Ross, 1960). Prior to transfusion, all subjects' sera were 
tested for pre-existing leukoagglutinins against their respective partner. 
Recipients' sera were tested again 1, 6 and days post transfusion 
for ~eukoagglutinins. Sera demonstrating leukoagglutinins against 
the specific blood donor were then tested against a panel of 11 
different leuko~ytes. The leukocytes for this panel were obtained 
from normal volunteer donors. 
A leukokinetic study the vitro DF32p label technique 
previously reported (Mauer, 1960) was done on each subject, giving 
the half-disappearance time of his own neutrophils from his blood 
(autologous Tl)' Two days later a unit of the donor's blood was 
2" 
labeled again with DF32p and transfused into the recipient. The 
resulting half disappearance time of donor's cells from the recipient's 
blood (isologous was compared to the autologous When the 
isologous was more than 40% shorter than the autologous Tl. it was 
2 
considered significantly shortened. The transfusion volume was greater 
than 400 ml of whole blood, thus more than 3.8XI09 leukocytes were 
given in each case. 
sera of all recipients showing an abnormally short isologous 
T1 , as well as those developing a leukogglutinin, w'ere tested for 
2' 
lymphocyte cytotoxic antibodies, All recipients' post transfusion 
sera were tested against a commercial red cell panel. 
II. Immunological Studies 
A. Leukoagglutination Test (Lalezari, 1964). 
1. Antibody Sources. 
The known pos:itive serum used in this study was obtained from 
National Institutes of Health (Vasques, #2-64-9-12-26-01, NIAID, Trans-
plantation and Immunology Branch, Bethesda, Md.) 
Fasting blood was collected and anticoagulated with 100th vol-
ume of 10% Na EDTA. Cell-poor plasma was collected after centrifuga-
2 
tion at 1,350 G for 30 minutes. Plasma specimens were stored in 1 ml 
aliquots at _20 0 C. Plasmas have been stored for over four years 
with no appreciable effect on the activity of various anttbodtes 
(Lalezari, 1964). Heat inactivation of plasmas before test is 
not necessary, but is serum is used complement must be inactivated 
by heating the sample to 560 C for 30 minutes. 
2. Leukocyte Preparation. 
Leukocytes are prepared at room temperature using siliconized 
glassware. Fasting blood is collected with a plastic syringe (usually 
20 ml) and anticoagluated with 100th volume of 10% Na EDTA. 10 ml 
2 
samples are transferred to 125X15 mm test tubes. Platelets are removed 
by differential centrifugation as fol~ows: Tubes are centrifuged at 
350 G for 15 minutes. Leukocytes layer on top of the red cells and 
14 
pla.telets remain suspended. Deceleration of the centrifuge must be 
slow to avoid resuspension of loosely sedimented leukocytes. The 
platelet rich supernate is removed completely with a pasteur ptpette 
and placed in another test tube. The supernate is then centrifuged 
at 1,350 G for 30 minutes. The resulting platelet poor plasma is 
returned to the tube containing the red cells and leukocytes. 0.2 
ml of 1% Polybrene (Abbott Laboratorie North Chicago) Ill.) in 
saline is added and the tube contents are mixed. The tube is tilted 
o 
at about 45 and left at room temperature for 30 minutes) allowing 
the red cells to sediment. In a SWinging head centrifuge the tubes 
are centrifuged at 15 G for 5 minutes, which leaves the leukocytes 
suspended. 
Contaminating red cells usually form a line on the side of 
the tube. These cells are sedimented by additional 5-minute centri-
o fugations at 15 G after rotating the tube 180 around its long axis. 
This is repeated until no red cell line forms (decelerate slowly). 
The leukocyte rich plasma is removed to another tube using a pasteur 
3 pipette, and the cell concentration ~ adjusted to about 4000/mm by 
dilution with autologous plasma. To each 9 volume of cell suspension 
1 volume of 10% Na(}:DTA is added. Cells thus prepared are kept at 
c::. 
room temperature and should be used within 7 hours from the time 
blood was collected. 
3. Test Procedure. 
The leukocyte agglutination test is performed with sertal double 
fold dilutions of test plasmas, from full strength plasma to 1:16 
dilution. 0.1 ml volwnes are used, w'ith saline as diluent in 75X12 
15 
mm nonsiliconized test tubes. O. ml cell suspension is added to 
each dilution. Controls are plasmas obtained from the respective 
leukocyte donors and their own cells, and one tube cells 
and physiologic saline. The tubes are sealed with Parafilm and placed 
in a 370 C water bath. Results of the test are determined after 5 and 
18 hours incubation. 
4. Interpretation of Tests, 
The tubes that are negative appear to have a clear 
with the nonagglutinated cells forming a homogenous film on the 
bottom of the tube. When agglutination occurs, the cells 
appear as floating white particles. Gross examination is confirmed 
by IOOX microscopy in dim light. The reactions are micro-
as follows: 4/; all of the cells participate in one or 
a few clumps} no free cells. 3/; aggregates are smaller and 
about 25% of the cells are free. 2/; smaller aggregations just 
vis ible wi.th t.he naked eye, 50% of the cell s are free. 11,; 
nation is not grossly visible, 75% of the cells are free. i no 
but groups of 3 or 4 cells are fairly common. 
tubes have no agglutinated cells or only occasional pairing. 'rhe 
type of cells involved in the agglutination reaction can be classi-
fied by 
has dried. 
the suspension on a slide and staining after it 
5. Comments. 
veal intact 
studies of leukocytes Pfepared with Polybrene re-
phagocytosis} and cell mobility. In this tech-
nique lymphocytes a.re partially removed. Polymorphonuclear cell recovery 
is over 50%. Prolonged incubation of the cell suspension with ABO 
incompatible plasmas containing no leukocyte agglutinins, even in 
16 
the presence of EDTA, results in occasional mixed erythrocyt.e-leuk.o-
cyte agglutination. This reaction can be distinguished microscopi-
cally from true leukoagglutination on the basis of red cells 
in the aggregate, which does not occur with true leukoagglutination. 
With storage, the leukocyte reactivity diminishes, but no 
significant changes occur within the first 5-7 hours after a blood 
sample is drawn. 
Leukoagglutinins are not detectable in nontransfused donors or 
nulliparous females. It may be assumed that a reaction 
indicates an acquired antibody (Lalezari, 1964). 
B. Lymphocyte Cytotoxic Test (modified from Terasaki, 1964). 
1. Antibody Sources. 
Fasting blood is drawn into clean glassware and allowed to clot~ 
Cell free serum is obtained and is either froxen in bulk or placed 
in disposable polystyrene micro-droplet-testing trays (Falcon Plastics, 
Los Angeles, .). 0.001 ml of serum is placed in the tray well., 
and covered with 1 drop of mineral oil. Each tray can accommodate 
60 antiserum samples, and are frozen at _60 0 C until used (Mittal, 
1968). 
2. Lymphocyte Preparation. 
10 ml of blood are collected and anticoagulated with 0.5 ml 
heparin (Heparin sodium, preservative free, River Labos, Northridge, 
Calif.). The blood is mixed well and placed in a large test tube 
with 2.5 ml of 4% polyvinylpyrrolidone (PVP, K-60, avg mol wt 160,000., 
17 
Matheson Coleman and Bell, East Rutnerford, N.J.) in saline, to 
sediment the red cells. After the red cells have sedimented suf1'i-
ciently, the supernate is draw'll off with a pasteur pipette and 
into a 20 ml disposable plastic syringe packed with nylon fibers 
(Leuko-Pak, Fenwal Laboratories, Morton Grove, Illinois). This is 
allow'ed to sit for 20 minutes at room temperature, which allows the 
platelets and granulocytes to adhere to the nylon fibers. With the 
syringe plunger the plasma, with the lymphocytes suspended, is expressed 
into 15 ml centrifuge tubes. The fleece is washed tW'ice with 5 ml 
Hanks' solution (Hyland Labs, Los Angeles, Calif.) and both washes 
are pressed into the centrifuge tubes with the plunger. These sus-
pensions of lymphocytes are centrifugated at about 1000 G for 10 min-
utes. The buffy coats are aspirated with a pasteur pipette and placed 
in a microcentrifuge tube. The tubes are centrifuged for 10 seconds 
at 11,000 RPM in a micro-centrifuge (Beckman Spinco model 152), the 
supernate is removed and the buffy coa.t is washed loose by squirting 
Hanks' solution from a pasteur pipette. The cell suspension is placed 
in a 5 ml beaker and to it 0.0025 ml specific red cell antiserum is 
added. Red cell agglutination is accomplished by horizontal shaking 
for 2 minutes, after which the lymphocyte suspension is placed in a 
microcentrifuge tube and spun for 2 seconds at slow RPM (about 1/3 
speed). The supernate is removed to another tube and the low speed 
s~ins are repeated until no contaminating red cells are seen. The 
supernate is removed and spun again at 11,000 RPM for 10 seconds to 
remove residual red cell antiserum. The lymphocytes are resuspended 
18 
in 0.4 ml Hanks! solution and the cell concentration is adjusted to 
1000,000/mm3• Lymphocytes thus prep~red can be used within 24 hours 
without undue loss of activity, and are stored at 2_80 C until used. 
3. Test Procedure. 
All of the components of the test system are placed in the wells 
with microsyringes (Hamilton Syringe Co., Fullerton, Calif.) operated 
by a pushbutton repeating dispensor (Hamilton PB-IOO). 
O.OOil ml of lymphocyte suspension is placed in each well of 
antiserum and incubated for 30 minutes at room temperature. 0.005 
ml c' is added to each well and incubated for 1 hour. The cells 
are stained in 1-2 minutes after adding 0.005 ml 5% aqueous eosin. 
The cells are fixed by adding 0.005 ml 40% formaldehyde at a pH of 
7.0. Mineral oil is gently poured over the entire surface of the 
testing tray and the cover is replaced. 
4. Interpretation of Tests. 
React.ions are read at 100X with an inverted phase contrast 
microscope. Living cells are round and refractile, while dead cells 
appear dark and somewhat larger. The reactions are scored numerically. 
Ij negative, all cells are alive, refractile and with distinct cell 
membranes. 2; negative but with 10% dead cells. 4; questionable, 
with 50% dead cells. 6; positive, with 75% dead cells; 25% cells 
still viable. 8; 100% dead cells. 
5. Comments. 
Repeated freezing and thawing of l~nphocytotoxic sera results 
in some decrease in antibody activity. Mittal, et ale (1968), found 
a 7.6% increase in negative reactions after alternately free and 
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thawing sera 7 times. Prozone effects are evident in about 10% of 
sera tested, and may be due to anticomplementary factors in the un-
diluted serum. For this reason the 
the incubation mixture. 
volume of C 1 is added to 
Cell concentration is critical, 1000 lymphocytes being t.he 
optimal number per well. After eosin is added to the well, some 
time must (1-2 minutes) before adding the formalin. False 
negative reactions l~ve been observed when eosin and formalin are 
added simultaneously. After fixation, tests can be read within 
hours (Mittal, 1968). 
C. Red Cell Antibody Test. 
1. Antibody Sources. 
Serum should be obtained from clotted blood and stored at 2_80 
C until used. Serum can be frozen if testing is to be delayed for 
long periods. Serum does not require heat inactivation. 
2. Red Cell Preparation. 
Red cell panels for antibody testing are best obtained commer-
cially. For best detection of antibodies an 8 and 16 cell panel is 
desirable (Panocell and Panocell-16, Pfizer Diagnostics, New Yor, N.y.). 
No additional processing 
commerical products. 
the red cell suspensions is needed with 
3. Test Procedure. 
A detailed test procedure is included with the red cell panel 
when purchased. In summary, the following methods are included: For 
the immediate spin 2 drops of serum and 1 drop red cell suspension 
are placed in each test tube and centrifuged at 1500 RPM for 1 minute, 
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after which the tubes are read. 2 drops of 30% bovine albumin are 
o then added and the tubes are incubated at 37 C for 30 minutes. The 
tubes are read again after centrifugation as before. An indirect 
Coombs test is then performed on the red cell after washing them 
tbree times in saline. 
4. Test Interpretation. 
Agglutination during any of the steps of the procedure indi-
cates the presence of an antibody in the serum. The type of antibody 
present can be found by referring to a master list of antibodies in .. 
cluded with the kit, and comparing the agglutination pattern with it. 
5. Comments. 
It has been generally accepted that the red cell antigenic 
system is in no way associated with the white cell antigens, however, 
this is still open to question and study (Dausset, 1970; Ceppellini, 
1964). A transfusion reaction caused by red cell incompatibility can 
be detected with these panels. 
EXPERIMENTAL RESULTS 
I. Pretransfusion Leukoagglutination Studies 
No leukoagglutinins were found in any donors I or recipients I 
plasmas before transfusion (Table 1). Each sub,ject I s plasma was 
tested against his partner I s leukocytes. Controls were set up wi tll 
the donor or recipientls own plasma and leukocytes and a known posi-
tive antiserum (see methods). Tests with this known antiserum pro-
duced agglutination of leukocytes in 58% of the donors (Table 1). 
The agglutination pattern was mixed (neutrophils and lymphocytes) up 
to a dilution of 1:4 and at higher dilutions consisted of aggregates 
of only neutrophilic granulocytes. 
II. Neutrophil Tl Studies 
2' 
Of the 12 isologous neutrophil disappearance rates, 4 were more 
than 40% shorter than their autologous Tl value. The varia t.i on t.ha t 
2' 
can be expected in the blood neutrophil value is '! 25% (CartwTight, 
1964), therefore, when the isologous was more than 40% shorter 
than the recipientls autologous it was considered significantly 
shortened. Except for recipient 9, all donors and recipients had 
normal autologous neutrophil kinetics (Table 2, Autologous Tl), 
2 
therefore, subsequent abnormal results were not because of a pre-
existing abnormality. 
The biphasic curve in pair number 7 is interpreted as a ~ type 
curve (Athens, 1965) in which case there is a short initial component 
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followed by an exponential with a normal (slower) 
It can be seen that there was no positive correlation between 
the volume of blood infused and the appearance of an agglutinin 
(Table 2). 
Recipient 9's abnormally short isologous is not nearly as 
short when compared to his unexplainably short autologous 
III. Post-transfusion Leukoagglutination Studies 
Three recipients developed leukoagglutinins after isologous 
transfusion (Table 3). An agglutinin was found in the serum of 
reCipient 11 on day 6 and in the sera of recipients 9 and 12 on day 
13. A fourth ~ubject's serum exhibited equivocal activity at 24 hours 
(number 2). In no case was a positive result seen that early. 
Of the reactive sera, number 9 exhibited the strongest activity, 
a 21 reaction at 13 days post-transfusion. This agglutinin caused 25% 
of the leukocytes of the leukocyte panel to agglutinate. Only the full 
strength serum showed any activity against the cell panel, while spec-
ific donor cells gave a I reaction at 1:2 dilution (Table 4). The 
other two positive sera, numbers 11 and 12, agglutinated only the spec-
ific donor leukocytes. Only the full strength sera of recipients 11 
and 12 showed agglutinating activity. All agglutination reactions were 
of the mixed type, involving neutrophils ~nd lymphocytes, which is 
consistent with the observations of Zmijewski (1968), who observed 
that lymphocytes will agglutinate in the presence of a minor population 
of agglutinating neutrophilic cells. Lymphocytes in pure suspension 
are not agglutinated by leukoagglutinins (Zmijewski, 1968). 
IV, Lymphocyte Cyto~oxicity Studies 
No lymphocyte cytotoxic antibodies were found in the post.-
transfusion sera of the recipients forming leukoagglutinins. These 
sera (numbers 2, 9, 11, 12) were tested against their respective cell 
donors and a panel of lymphocytes. Lymphocytes for the panel were 
obtained from normal blood donors. Though 0.001 ml of serum is nor-
mally used, this test was set up using 0.001 and 0.002 ml of serum 
for each specific lymphocyte suspension tested. This was done to in-
crease the chance that any low titered antibodies present in the serum 
would be present in sufficient quantity to react with the lymphocytes 
in the well. 
V. Red Cell Antibody Studies 
No red cell antibodies were found when post-transfusion sera 
were tested against 8 and 16 cell commercial screening panels (Pano-
cell and Panocell-16, Pfizer Diagnostics, New York). All tw'elve 
recipients I post-transfusion sera were tested. Red cell agglutination 
was checked for microscopically after the immediate spin, warm incu-
bation, high protein and indirect Coombs' test portions of the pro-
cedure. 
Recipient 2 had a detectable but very weak ~ncomp~tibility 
when he was cross matched with his partner post-transfusion. No in~ 

















*Dilutions of serum Vasques 
TABLE 1 
Pretransfusion Leukoagglutination Tests 
Recipient serum 
and cells 
Donor cells Donor serum 
recipient serum recipient cells 
Positive control sera 
with donor cells 





















Neutrophil T.!. Values Following Autologous and Isologous 
2 Transfus ion 
Autologous T.!. (hrs.) Recipient isologous Significantly Recipient isologous 
Transfusion pair Donor R~c transfusion (hrs. ) shortened transfusion volume (ml) 
1 7.3 9.0 5.0 Yes 481.0 
2 5.5 5.7 6.6 No 578.5 
3 7.0 4.7 4.6 No 500.0 
4 5.8 6.3 4.8 No 623.5 
5 7.0 7.7 5.2 No 619.5 
6 8.0 5.0 5.0 No 568.7 
7 9·0 5.0 1. & 2 No 507.0 
8 5.7 6.5 6.3 No 534.5 
9 6.6 2.3 1.5 No 562.0 
10 11.6 9·3 4.3 Yes 409.0 
11 8.6 7.5 4.2 Yes .0 
12 7.75 10.2 1.0 Yes 530.5 
*Biphasic curve, see Discussion for explanation. 
TABLE 3 
Appearance of Serum Leukoagglutinins Following Isologous Transfusion 
24 hr. Post-* 6 Day Post-* 13 Day Post-* 
































* Donor cells vs donor plasma, recipient cells vs recipient plasma 
and rec~pient cells vs donor plasma controls were always positive. 
Reaction key: 0 = not tested 

DISCUSSION 
I. Experimental Results 
No leukoagglutinins were found in the pretransfusion serum of 
any subject used in this study. These results support those of 
Lalezari (1964) who noted that pregnancy or precious blood transfusion 
were necessary prerequisites for agglutinin formation. Only one 
subject (donor 9) out of the twelve pairs used admitted to previous 
transfusion. The fact that his serum contained no agglutinin is not 
surprising when compared with the experiments done by Ceppellini (1964), 
who over a period of one year transfused as much as 1200 ml of whole 
blood in multiple small doses. Many of his recipients failed to 
develop agglutinins against the donor. 
The strong known antiserum (see results, Table 1) produced 
agglutination of 58% of a donor cell panel. The reaction pattern 
of mixed agglutination at dilutions less than 1:8 and neutrophils 
only at higher dilutions, supports previous findings with neutrophil 
specific antiserum (Lalezari, 1970). There was an apparent prozone 
effect caused by the concentrated antiserum (Table 1, 1:2 dilution 
of antiserum with donors 2 and 9) • 
Previous studies have indicated that 7 of 22 isologous neutro-
phil TIS were abnormally short (Mauer, 1960; Kauder, 1965), which 
:2 
correlates well with the 4 of 12 of this study (Table 2). 
A 'B I type curve (Table 2, recipient 7) is thought to be caused 
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by an influx of cells from the bone marrow to the circulation wtlich 
w'ill dilute the DF32p labeled cells, or a reutilization of the label 
from cells that are in some way disrupted_ A comparison of columns 
2, 3 and 4 of Table 2 suggests that donor neutrophils transfused to 
an isologous recipient have a Tl similar to the recipients 1 auto-
2 
logous T~, when the recipients' isologous 
2 
is not changed. The 
transfused leukocytes behave as though they were the rec 
own leukocytes. 
Recipient 9 (Table 2) had an abnormally short autologous T1 -
~t 
He is a confirmed drug addict and was taking drugs i.v. just previous 
to the study. The negative medical history that qualified him as a 
subject should be suspect, as should his apparent normal physiology. 
The leukoagglutination test of Lalezari is highly reproducible, 
The results listed in Table 4 were obtained 4-6 months after those 
in Table 3, and show that reactions of positive sera with 
donor leukocytes are not The t. reaction of recipient 2 
(Table 3) was also t at this late:r testing, while having a normal 
autologous control. Weak reactions in control tubes were not seen. 
If agglutination does occur in control tubes it can be eliminated by 
having a low leukocyte concentration (4000/mm3) and by adding extra 
EDTA to the cell suspension. The weak (!:") reactions seen with recip-
ient 2, 12 (Table 3), and with several members of the leukocyte 
panel (Table 4) are considered not to be positive. This is because 
-.t reactions tend to be non-reproducible and inconsistent as well 
as nonspecific (Lalezari, 1964). Note, however, that recipient 12 
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showed'!: reactivity of day 6 and developed a positive result on day 
13. The higher titered agg;Lutinin seen in recipient 9 may be the 
result of the isologous transfusion or an anamnestic response to 
previous sensitization. His serum agglutinated 25% of the leukoeytes 
of the cell :panel and the specific donor leukocytes, but not his own 
leukocytes. 
In three subjects leukogglutinins were formed post-transfusion 
and on testing no lymphocyte cytotoxic antibodies were detectable 
in these same sera. It has been reported by other workers that 
leukoagglutination reactions can take place using a specific serum 
without cytotoxic antibodies being demonstrable (Walford, 1969). 
These leukoagglutinins probably detect antigens different from those 
detected by the cytotoxic technique, as suggested by Zmijewski (1966). 
The weak red cell incompatibility found in recipient 2 post-
transfusion seems to have no affect on the leukocytes. Post-
transfusion leukocyte agglutination studies were not positive and 
his isologous was normal. 
II. Appearance of a Leukoagglutinin and the Possible 
Correlation with Shortened Isologous 
There is an 85% chance that antigenic differences between donor 
and recipient are responsible for shortened isologous Tl values 
2" 
(Table 5, p = 0.15). Tw'o-thirds of the recipients developing a post-
transfusion agglutinin had a shortened T1 , while 2/4 of the recipients 
2" 
with a shortened Tl value developed leukoagglutinins (Table 5). 
2" 
There is an inherent sensitivity difference between the leukokinetic 
test and the leukoagglutination test, in that the leukokinetic test 
is done in.Y.!Y2 while the agglutination test is done in vitro. It 
is well established that the body is a much more sensitive detector 
of physiologic and biochemical differences, as evidenced by graft 
rejection, transfusion reactions, etc. Therefore, it could be 
that the in vivo leukokinetic test detected a differenc~ between donor 
and recipient that was not significant enough to cause a detectable 
agglutinin to be formed. In his attempt to produce leukoagglutirdns 
Ceppellini brought out several significant facts. Even though a re-
cipient develops no detectable leukoagglutinins after transfusion 
he is still sensitized, as evidenced by a second set rejection of 
a tissue transplant from this same donor. "In other words, not all 
histocompatibility factors manifest themselves as leukoagglutinins 
after multiple i~v. transfusions, and graft (tissue) rejection is 
a much more sensitive test for detecting isoantigenic differences 
tban the appearance of leukoagglutinins" (Ceppellini, 1964). 
Blood is a tissue and when transfused to a recipient could be 
thought of as an erythrocyte and leukocyte graft. The Tl could be 
"2 
a measure of neutrophil 'gr~ft' rejection. 
There are several suggestions that would make a future study 
more definitive. A stable population should be chosen for the study 
that could be available for up to 2 years. A larger more statisti-
cally significant population should be used (expensive) with the 
pairs being used two, three, or even four times for transfusion on 
a suitable schedule. In fact in this study an attempt was made to 
follow up the short Tl in recipient 10. Pair 10 was taken through 
"2 
an autologous study again, and were to be used in another isologous 
32 
study, in an attempt to stimulate agglutinin production. How'ever, 
they took a leave of absence before this could be accomplished 
(unauthorized leave). 
Such future follow' up studies would allow the possible forma-
tion of leukocyte antibodies to be detected, as well as additional 
effects of the leukokinetic study. 
r:J.'ABLE 5 

















*By 2 X 2 X2, P = o. 
**Isologous more than shorter than autologous 
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